VivoSeq
Other

Perioperative Bleeding

0

Pipeline Programs

3

Active Trials

1

Companies Involved

Perioperative Bleeding is an early-stage landscape with 0 programs across 1 company. The most active players are CSL Behring.

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

80/100

Attrition Rate

15/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

13

clinical trials

Completed8 · 62%
Recruiting2 · 15%
Withdrawn1 · 8%
Terminated1 · 8%
Not yet recruiting1 · 8%

Trial Activity

13 trials

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)